Next Generation Antidepressants

Next Generation Antidepressants : Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders

2 (1 rating by Goodreads)
  • Electronic book text
Edited by  , Edited by 

List price: US$80.00

Currently unavailable

We can notify you when this item is back in stock

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.show more

Product details

  • Electronic book text
  • CAMBRIDGE UNIVERSITY PRESS
  • Cambridge University Press (Virtual Publishing)
  • Cambridge, United Kingdom
  • 27 b/w illus. 10 tables
  • 1139832573
  • 9781139832571

Review quote

'This is a very useful and interesting publication with a great deal of clearly summarised information on biological depression research. It gives a concise overview of likely future directions for new treatments.' The British Journal of Psychiatryshow more

Table of contents

Preface Chad E. Beyer; 1. Current depression landscape: a state of the field today Laurence Mignon and Stephen M. Stahl; 2. Novel therapeutic targets for treating affective disorders Eliyahu Dremencov and Thomas Cremers; 3. Developing novel animal models of depression Lotte de Groote, Malgorzata Filip and Andrew C. McCreary; 4. Translational research in mood disorders: using imaging technologies in biomarker research Jul Lea Shamy, Adam M. Brickman, Chris D. Griesemer, Anna Parachikova and Mark Day; 5. Defining depression endophenotypes Lisa H. Berghorst and Diego A. Pizzagalli; 6. Genetic and genomic studies of major depressive disorder Roy H. Perlis; 7. Medicinal chemistry challenges in the design of next generation antidepressants David P. Rotella; 8. Application of pharmacogenomics and personalized medicine for the care of depression Keh-Ming Lin, Chun-Yu Chen and Yu-Jui Yvonne Wan; Index.show more

About Chad E. Beyer

Chad E. Beyer is Prinicpal Research Scientist II at Pfizer Global Research and Development, Princeton, New Jersey and Adjunct Professor at Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California San Diego, San Diego, California, and Neuroscience Education Institute, Carlsbad, California, USA.show more

Rating details

1 ratings
2 out of 5 stars
5 0% (0)
4 0% (0)
3 0% (0)
2 100% (1)
1 0% (0)
Book ratings by Goodreads
Goodreads is the world's largest site for readers with over 50 million reviews. We're featuring millions of their reader ratings on our book pages to help you find your new favourite book. Close X